Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040147 | SCV000063838 | benign | not specified | 2015-05-06 | criteria provided, single submitter | clinical testing | p.Ala9671Pro in exon 130 of TTN: This variant is not expected to have clinical s ignificance because it has been identified in 1.0% (98/9782) of African chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs72650032). |
Eurofins Ntd Llc |
RCV000040147 | SCV000114373 | benign | not specified | 2016-12-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001573207 | SCV000237088 | likely benign | not provided | 2020-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000251106 | SCV000319194 | benign | Cardiovascular phenotype | 2013-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000459932 | SCV000555429 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000040147 | SCV000597658 | likely benign | not specified | 2015-08-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000040147 | SCV000616060 | benign | not specified | 2017-05-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040147 | SCV001821478 | likely benign | not specified | 2021-08-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839585 | SCV002101770 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839586 | SCV002101771 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839587 | SCV002101772 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839584 | SCV002101773 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001573207 | SCV004562058 | benign | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004534892 | SCV004733818 | benign | TTN-related disorder | 2021-01-11 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV001573207 | SCV001798710 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000040147 | SCV001926112 | benign | not specified | no assertion criteria provided | clinical testing |